CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 540 enrolled
Drug / intervention
Acetaminophen +1 moredrug
Likely dose
Placebo Control 0 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01115673
NCT01115673Phase 3Completed

A Single-Center, Randomized, Double-Blind, Placebo-Controlled, Single-Dose, Safety and Efficacy Study of Acetaminophen 1000 mg and Acetaminophen 650 mg in Post Operative Dental Pain

McNeil Consumer Healthcare Division of McNEIL-PPC, Inc.·interventional·Posted May 4, 2010·Updated May 28, 2012

In Brief

A Phase 3 clinical trial evaluating Acetaminophen and Placebo Control for Pain. Completed, enrolled 540 participants across 1 site.

Detailed Summary

The objective of this study is to evaluate the safety and efficacy of acetaminophen 650 mg and acetaminophen 1000 mg in dental surgery.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain
CountriesUnited States
Collaborators--

Timeline

Phase 3CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedMay 4, 2010
Enrollment StartJun 1, 2010
Primary CompletionJan 1, 2011
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 16.2 years ago

Interventions

Acetaminophendrug

Acetaminophen Caplet - single dose

Placebo Controldrug

0 mg Caplet - single dose